A combination of four genes (p16, ARF, MGMT, and GSTP1) has been proposed to detect prostate cancer with an estimated 87% sensitivity and 100% specificity (Hoque et al. 2005). The gene discussed is CDKN2A; the disease is prostate carcinoma.